B of A Securities Downgrades Definitive Healthcare to Underperform, Lowers Price Target to $0.7
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsDowngradesPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
B of A Securities analyst Allen Lutz downgrades Definitive Healthcare (NASDAQ:DH) from Buy to Underperform and lowers the price target from $3.5 to $0.7.
B of A Securities analyst Allen Lutz downgrades Definitive Healthcare (NASDAQ:DH) from Buy to Underperform and lowers the price target from $3.5 to $0.7.